These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 20223190)

  • 21. Highly sensitive histamine-sensitization test for residual activity of pertussis toxin in acellular pertussis vaccine.
    Ochiai M; Yamamoto A; Kataoka M; Toyoizumi H; Arakawa Y; Horiuchi Y
    Biologicals; 2007 Oct; 35(4):259-64. PubMed ID: 17363269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative study for the establishment of tetanus vaccine (adsorbed) Third International Standard and European Pharmacopoeia Biological Reference Preparation batch no. 2.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):45-72. PubMed ID: 11705100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calibration of the Ph. Eur. BRP Batch 3/Mega 2 (US/FDA) standard for human coagulation factor VIII concentrate for use in the potency assay.
    Kirschbaum N; Wood L; Lachenbruch P; Weinstein M; Daas A; Rautmann G; Spieser JM; Buchheit KH
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):31-64. PubMed ID: 12448031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the bioactivity of reference preparations for assaying Bordetella pertussis toxin activity in vaccines by the histamine sensitisation and Chinese hamster ovary-cell tests: assessment of validity of expression of activity in terms of protein concentration.
    Xing D; Das RG; Newland P; Corbel M
    Vaccine; 2002 Oct; 20(29-30):3535-42. PubMed ID: 12297399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved protocols for histamine sensitization testing of acellular pertussis vaccines.
    Oh H; Joung J; Kim BG; Nam KT; Hong SH; Song HC; Lee HL; Ahn BY
    Vaccine; 2012 Nov; 30(50):7246-52. PubMed ID: 23084771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
    Terao E; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In search of acceptable alternatives to the murine histamine sensitisation test (HIST): what is possible and practical?
    Wagner L; Isbrucker R; Locht C; Arciniega J; Costanzo A; McFarland R; Oh H; Hoonakker M; Descamps J; Andersen SR; Gupta RK; Markey K; Chapsal JM; Lidster K; Casey W; Allen D
    Pharmeur Bio Sci Notes; 2016; 2016():151-170. PubMed ID: 28279256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Collaborative study on test systems to assess toxicity of whole cell pertussis vaccine.
    van Straaten-van de Kappelle I; van der Gun JW; Marsman FR; Hendriksen CF; van de Donk HJ
    Biologicals; 1997 Mar; 25(1):41-57. PubMed ID: 9167008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.
    Gomez SR; Yuen CT; Asokanathan C; Douglas-Bardsley A; Corbel MJ; Coote JG; Parton R; Xing DK
    Vaccine; 2007 Apr; 25(17):3311-8. PubMed ID: 17287049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity and detection limit of a dermal temperature histamine sensitization test for absence of residual pertussis toxin in vaccines.
    Jensen SE; Illigen KE; Badsberg JH; Hasløv KR
    Biologicals; 2012 Jan; 40(1):36-40. PubMed ID: 22000164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for Clostridia antiserum for serological potency testing of veterinary clostridial vaccines.
    Lucken R; Daas A; Behr-Gross ME
    Dev Biol (Basel); 2002; 111():171-80. PubMed ID: 12678238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Workshop on Animal free Detection of Pertussis Toxin in Vaccines--Alternatives to the Histamine Sensitisation Test.
    Bache C; Hoonakker M; Hendriksen C; Buchheit KH; Spreitzer I; Montag T
    Biologicals; 2012 Jul; 40(4):309-11. PubMed ID: 22609106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collaborative study for the calibration of the replacement International Standard for pertussis toxin for use in histamine sensitisation and CHO cell clustering assays.
    Douglas-Bardsley A; Asokanathan C; Tierney S; Hockley J; Markey K
    Biologicals; 2019 Nov; 62():85-92. PubMed ID: 31526657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
    Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Towards replacement of the acellular pertussis vaccine safety test: Comparison of in vitro cytotoxic activity and in vivo activity in mice.
    Wagner LD; Corvette LJ; Ngundi MM; Burns DL
    Vaccine; 2017 Dec; 35(51):7160-7165. PubMed ID: 29122386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Key points for the development of mouse immunogenicity test as potency assay for acellular pertussis vaccines.
    André M; Poirier B; Bornstein N; Marmonier D; El Zaouk A; Fuchs F
    Biologicals; 2000 Dec; 28(4):217-25. PubMed ID: 11237357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
    Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
    Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaborative study for the establishment of erysipelas ELISA coating antigen. European Biological Reference Preparation batch no. 1.
    Cussler K; Rosskopf-Streicher U; Volkers P; Milne C
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):75-88. PubMed ID: 11705102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.